Omnipaque Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3
Condition:   Heart Failure Interventions:   Drug: LCZ 696;   Drug: Placebo;   Drug: Para-aminohippurate;   Drug: Iohexol;   Drug: Aprepitant Sponsor:   Yale University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2020 Category: Research Source Type: clinical trials

Comparison of Captisol-Enabled ™ Iohexol and Omnipaque™ in Patients With Impaired Renal Function Undergoing Coronary Angiography
Condition:   Contrast-induced Nephropathy Interventions:   Drug: CE-Iohexol;   Drug: Iohexol Sponsor:   Ligand Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2020 Category: Research Source Type: clinical trials